Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breckenridge

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|March 12, 1999
Clinical pharmacology and drug regulationA Breckenridge
Drugs|January 1, 1988
Ageing, serotonin and ketanserinA Breckenridge
British Heart Journal|January 1, 1971
Prognosis of treated hypertensionA Breckenridge
The British Journal of Dermatology|February 1, 1992
Clinical significance of interactions with antifungal agentsA Breckenridge
British Medical Journal (Clinical Research Ed.)|October 6, 1984
The third drug in hypertensionA Breckenridge
British Medical Journal (Clinical Research Ed.)|July 3, 1982
Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpointA Breckenridge
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 31, 1977
Drug interactions during metabolism in the liverA Breckenridge
Journal of Cardiovascular Pharmacology|January 1, 1988
Age-related effects of angiotensin converting enzyme inhibitorsA Breckenridge
Journal of Cardiovascular Pharmacology|January 1, 1985
Angiotensin converting enzyme inhibition in clinical practice. Re-examination of step care: choice of first drugA Breckenridge
Clinical Pharmacokinetics|May 1, 1980
Antipyrine half-life and drug eliminationA Breckenridge
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|March 12, 1999
Clinical pharmacology and drug regulationA Breckenridge
Drugs|January 1, 1988
Ageing, serotonin and ketanserinA Breckenridge
British Heart Journal|January 1, 1971
Prognosis of treated hypertensionA Breckenridge
The British Journal of Dermatology|February 1, 1992
Clinical significance of interactions with antifungal agentsA Breckenridge
British Medical Journal (Clinical Research Ed.)|October 6, 1984
The third drug in hypertensionA Breckenridge
British Medical Journal (Clinical Research Ed.)|July 3, 1982
Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpointA Breckenridge
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 31, 1977
Drug interactions during metabolism in the liverA Breckenridge
Journal of Cardiovascular Pharmacology|January 1, 1988
Age-related effects of angiotensin converting enzyme inhibitorsA Breckenridge
Journal of Cardiovascular Pharmacology|January 1, 1985
Angiotensin converting enzyme inhibition in clinical practice. Re-examination of step care: choice of first drugA Breckenridge
Clinical Pharmacokinetics|May 1, 1980
Antipyrine half-life and drug eliminationA Breckenridge
Pageof 14